Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• DesantisCMaJBryanLJemalABreast cancer statistics, 2013CA Cancer J Clin2014641526224114568
   PubMed Web of Science ®Google Scholar
• DawoodSBroglioKEnsorJHortobagyiGNGiordanoSHSurvival differences among women with de novo stage IV and relapsed breast cancerAnn Oncol201021112169217420427349
   PubMed Web of Science ®Google Scholar
• RedigAJMcallisterSSBreast cancer as a systemic disease: a view of metastasisJ Intern Med2013274211312623844915
   PubMed Web of Science ®Google Scholar
• PerouCMSørlieTEisenMBMolecular portraits of human breast tumoursNature2000406679774775210963602
   PubMed Web of Science ®Google Scholar
• PratAPerouCMDeconstructing the molecular portraits of breast cancerMol Oncol20115152321147047
   PubMed Web of Science ®Google Scholar
• SørlieTTibshiraniRParkerJRepeated observation of breast tumor subtypes in independent gene expression data setsProc Natl Acad Sci U S A2003100148418842312829800
   PubMed Web of Science ®Google Scholar
• RouzierRPerouCMSymmansWFBreast cancer molecular subtypes respond differently to preoperative chemotherapyClin Cancer Res200511165678568516115903
   PubMed Web of Science ®Google Scholar
• SmidMWangYZhangYSubtypes of breast cancer show preferential site of relapseCancer Res20086893108311418451135
   PubMed Web of Science ®Google Scholar
• SoniARenZHameedOBreast cancer subtypes predispose the site of distant metastasesAm J Clin Pathol2015143447147825779997
   PubMed Web of Science ®Google Scholar
• GerratanaLFanottoVBonottoMPattern of metastasis and outcome in patients with breast cancerClin Exp Metastasis201532212513325630269
   PubMed Web of Science ®Google Scholar
• HarrellJCPratAParkerJSGenomic analysis identifies unique signatures predictive of brain, lung, and liver relapseBreast Cancer Res Treat2012132252353521671017
   PubMed Web of Science ®Google Scholar
• KastKLinkTFriedrichKImpact of breast cancer subtypes and patterns of metastasis on outcomeBreast Cancer Res Treat2015150362162925783184
   PubMed Web of Science ®Google Scholar
• ChanSFriedrichsKNoelDProspective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancerJ Clin Oncol19991782341235410561296
   PubMed Web of Science ®Google Scholar
• LeeYTBreast carcinoma: pattern of metastasis at autopsyJ Surg Oncol19832331751806345937
   PubMed Web of Science ®Google Scholar
• MartyMCognettiFMaraninchiDRandomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study groupJ Clin Oncol200523194265427415911866
   PubMed Web of Science ®Google Scholar
• CummingsMCSimpsonPTReidLEMetastatic progression of breast cancer: insights from 50 years of autopsiesJ Pathol20142321233124122263
   PubMed Web of Science ®Google Scholar
• O’ReillySMRichardsMARubensRDLiver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survivalEur J Cancer19902655745772144744
   PubMed Web of Science ®Google Scholar
• HoeALRoyleGTTaylorIBreast liver metastases – incidence, diagnosis and outcomeJ R Soc Med199184127147161774744
   PubMed Web of Science ®Google Scholar
• DiamondJRFinlaysonCABorgesVFHepatic complications of breast cancerLancet Oncol200910661562119482250
   PubMed Web of Science ®Google Scholar
• PerezJEMachiavelliMLeoneBABone-only versus visceral-only metastatic pattern in breast cancer: analysis of 150 patients. A GOCS study. Grupo Oncológico Cooperativo del SurAm J Clin Oncol19901342942982198793
   PubMedGoogle Scholar
• MussHBEndocrine therapy for advanced breast cancer: a reviewBreast Cancer Res Treat199221115261382723
   PubMed Web of Science ®Google Scholar
• AdamRAloiaTKrissatJIs liver resection justified for patients with hepatic metastases from breast cancer?Ann Surg2006244689790817122615
   PubMed Web of Science ®Google Scholar
• BubnovRPolivkaJZuborPKonieczkaKGolubnitschajaO“Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset? “Flammer syndrome” relevance to address the questionEpma J20178214115728725292
   PubMed Web of Science ®Google Scholar
• HessKRVaradhacharyGRTaylorSHMetastatic patterns in adenocarcinomaCancer200610671624163316518827
   PubMed Web of Science ®Google Scholar
• GolubnitschajaOSridharKCLiver metastatic disease: new concepts and biomarker panels to improve individual outcomesClin Exp Metastasis201633874375527541751
   PubMed Web of Science ®Google Scholar
• GolubnitschajaOFilepNYeghiazaryanKBlomHJHofmann-ApitiusMKuhnWMulti-omic approach decodes paradoxes of the triple-negative breast cancer: lessons for predictive, preventive and personalised medicineAmino Acids2018503–438339529249020
   PubMed Web of Science ®Google Scholar
• FröhlichHPatjoshiSYeghiazaryanKKehrerCKuhnWGolubnitschajaOPremenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratificationEpma J20189217518629896316
   PubMed Web of Science ®Google Scholar
• ErOFryeDKKauSWClinical course of breast cancer patients with metastases limited to the liver treated with chemotherapyCancer J2008141626818303485
   PubMed Web of Science ®Google Scholar
• PentheroudakisGFountzilasGBafaloukosDMetastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 womenBreast Cancer Res Treat200697323724416322882
   PubMed Web of Science ®Google Scholar
• WyldLGutteridgeEPinderSEPrognostic factors for patients with hepatic metastases from breast cancerBr J Cancer200389228429012865918
   PubMed Web of Science ®Google Scholar
• AtalayGBiganzoliLRenardFClinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trialsEur J Cancer200339172439244914602130
   PubMed Web of Science ®Google Scholar
• GeQDLvNKongYNClinical characteristics and survival analysis of breast cancer molecular subtypes with hepatic metastasesAsian Pac J Cancer Prev201213105081508623244114
   PubMed Web of Science ®Google Scholar
• DuanXFDongNNZhangTLiQThe prognostic analysis of clinical breast cancer subtypes among patients with liver metastases from breast cancerInt J Clin Oncol2013181263222041927
   PubMed Web of Science ®Google Scholar
• LobbezooDJvan KampenRJVoogdACPrognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcomeBreast Cancer Res Treat2013141350751424104881
   PubMed Web of Science ®Google Scholar
• BartmannCDiessnerJBlettnerMFactors influencing the development of visceral metastasis of breast cancer: a retrospective multi-center studyBreast201731667527816834
   PubMed Web of Science ®Google Scholar
• YardleyDAKaufmanPABrufskyATreatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancerBreast Cancer Res Treat2014145372573424706168
   PubMed Web of Science ®Google Scholar
• DawoodSBroglioKBuzdarAUHortobagyiGNGiordanoSHPrognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based reviewJ Clin Oncol2010281929819933921
   PubMed Web of Science ®Google Scholar
• Leyland-JonesBHuman epidermal growth factor receptor 2-positive breast cancer and central nervous system metastasesJ Clin Oncol200927315278528619770385
   PubMed Web of Science ®Google Scholar
• ChenXSunLCongYBaseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancerJ Exp Clin Cancer Res20143312824628817
   PubMedGoogle Scholar
• LeoneBAVallejoCTRomeroAOPrognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosisBreast Cancer Res Treat2017161353754827975154
   PubMed Web of Science ®Google Scholar
• PressDJMillerMELiederbachEYaoKHuoDDe novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtypeClin Exp Metastasis201734845746529288366
   PubMed Web of Science ®Google Scholar
• LiYMPanYWeiYUpregulation of CXCR4 is essential for HER2-mediated tumor metastasisCancer Cell20046545946915542430
   PubMed Web of Science ®Google Scholar
• PierobonMRamosCWongSEnrichment of PI3K-AKT-mTOR pathway activation in hepatic metastases from breast cancerClin Cancer Res201723164919492828446508
   PubMed Web of Science ®Google Scholar
• KimbungSJohanssonIDanielssonATranscriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal a primary breast cancerClin Cancer Res201622114615726276891
   PubMed Web of Science ®Google Scholar
• GolubnitschajaOYeghiazaryanKStrickerHTrogDSchildHHBerlinerLPatients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumoursBMC Cancer201616135727277077
   PubMedGoogle Scholar
• BanerjeeDHernandezSLGarciaANotch suppresses angiogenesis and progression of hepatic metastasesCancer Res20157581592160225744722
   PubMed Web of Science ®Google Scholar
• PolivkaJKralickovaMPolivkaJKaiserCKuhnWGolubnitschajaOMystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon?Epma J20178211912728824737
   PubMed Web of Science ®Google Scholar
• PurushothamAShamilECariatiMAge at diagnosis and distant metastasis in breast cancer – a surprising inverse relationshipEur J Cancer201450101697170524768572
   PubMed Web of Science ®Google Scholar
• SemenzaGLCancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasisOncogene201332354057406323222717
   PubMed Web of Science ®Google Scholar
• MaRFengYLinSMechanisms involved in breast cancer liver metastasisJ Transl Med20151316425885919
   PubMedGoogle Scholar
• MiaoHVerkooijenHMChiaKSIncidence and outcome of male breast cancer: an international population-based studyJ Clin Oncol201129334381438621969512
   PubMed Web of Science ®Google Scholar
• AndersonWFJatoiITseJRosenbergPSMale breast cancer: a population-based comparison with female breast cancerJ Clin Oncol201028223223919996029
   PubMed Web of Science ®Google Scholar
• PockajBAWasifNDueckACMetastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look?Ann Surg Oncol20101792419242620232163
   PubMed Web of Science ®Google Scholar
• CrumpMGluckSTuDRandomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16J Clin Oncol2008261374318025439
   PubMed Web of Science ®Google Scholar
• TaoLChuLWangLIOccurrence and outcome of de novo metastatic breast cancer by subtype in a large, diverse populationCancer Causes Control20162791127113827496200
   PubMed Web of Science ®Google Scholar
• AbbasHErridgeSSodergrenMHBreast cancer liver metastases in a UK tertiary centre: outcomes following referral to tumour board meetingInt J Surg20174415215928645556
   PubMed Web of Science ®Google Scholar
• MartinAMCagneyDNCatalanoPJBrain metastases in newly diagnosed breast cancer: a population-based studyJAMA Oncol2017381069107728301662
   PubMed Web of Science ®Google Scholar
• SchrijverWAMESuijkerbuijkKPMvan GilsCHvan der WallEMoelansCBvan DiestPJReceptor conversion in distant breast cancer metastases: a systematic review and meta-analysisJ Natl Cancer Inst2018110656858029315431
   PubMedGoogle Scholar